The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis

Evidence of the prognostic role of serine peptidase inhibitor Kazal type 1 (SPINK1) in prostate cancer (PCa) is controversial. The aim of this study was, therefore, to evaluate the association between SPINK1 and clinical outcomes in PCa. Searches were made of PubMed, Medline, Embase, and the China B...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xingming, Yin, Xiaoxue, Shen, Pengfei, Sun, Guangxi, Yang, Yaojing, Liu, Jiandong, Chen, Ni, Zeng, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488756/
https://www.ncbi.nlm.nih.gov/pubmed/28790846
http://dx.doi.org/10.2147/OTT.S127317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488756/
https://www.ncbi.nlm.nih.gov/pubmed/28790846
http://dx.doi.org/10.2147/OTT.S127317

Ejemplares similares